Introducing drug-anti-body conjugates cover art

Introducing drug-anti-body conjugates

Introducing drug-anti-body conjugates

Listen for free

View show details

About this listen

Dr Lizanne Langenhoven details how knowing the subtype of breast cancer determines treatment, and introduces the new drug-antibody conjugates for HER2-positive breast cancer.

Dr Lizanne Langenhoven is a clinical and radiation oncologist at Panorama Mediclinic and forms part of a multi-disciplinary unit of excellence in the treatment of breast cancer at the Panorama Centre for Surgical Oncology. Facebook · Twitter · Instagram · LinkedIn
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.